While human malignant mesothelioma is extremely resistant to chemotherapy, its intrinsic resistance mechanisms remain largely unknown. In this study, we used normal human mesothelial cells and 5 human mesothelioma cell lines not previously exposed to chemotherapeutic agents to demonstrate that the m
Co-expression of gamma-glutamylcysteine synthetase sub-units in response to cisplatin and doxorubicin in human cancer cells
โ Scribed by Tetsuya Iida; Eri Mori; Katsuharu Mori; Shinji Goto; Yoshishige Urata; Mikio Oka; Shigeru Kohno; Takahito Kondo
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- French
- Weight
- 178 KB
- Volume
- 82
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
โฆ Synopsis
Glutathione (โฅ-glutamylcysteinyl glycine, GSH) is believed to be important in the acquisition of resistance to anti-cancer drugs such as cisplatin (CDDP) and doxorubicin (DOX). โฅ-Glutamylcysteine synthetase (โฅ-GCS) is a key enzyme for maintaining intracellular GSH levels; it is composed of a catalytic heavy (โฅ-GCSh) and a regulatory light (โฅ-GCSl) sub-unit. In the present study, the expression of โฅ-GCS sub-units was examined in human cancer cell lines. The levels of GSH, the expression of โฅ-GCSh and โฅ-GCSl mRNAs and proteins in human cancer cells were higher in CDDPresistant cells and DOX-resistant cells than in the drugsensitive cells. Treatment of CDDP/DOX-resistant human colonic-cancer cells (HCT8DDP) with CDDP and DOX caused simultaneous induction of the expression of โฅ-GCSh and โฅ-GCSl mRNAs. The transcriptional regulation of โฅ-GCS was studied and it was observed that the DNA-binding activity of activator protein 1 (AP-1) is induced by CDDP and DOX using an electrophoretic mobility shift assay. We constructed chimeric genes containing various regions of the โฅ-GCShpromoter gene and the coding region for luciferase. The HCT8DDP cells transiently transfected with a plasmid containing an AP-1 site of the โฅ-GCSh-promoter-luciferase construct showed increased luciferase activity when treated with CDDP and DOX. These results suggest that stimulation of the expression of โฅ-GCSh by CDDP and DOX is mediated by AP-1, which relates to the resistance of cancer cells to the drug.
๐ SIMILAR VOLUMES
BACKGROUND. BRCA1 and BRCA2 participate in cell cycle progression, apoptosis, and DNA repair pathways. The latter role may be mediated by interaction with DNA recombinase Rad51. The purpose of this study was to evaluate the effects of genotoxic and other cytotoxic agents on expression of DNA damage-
Although it is well recognised that human meningiomas are rich in progesterone receptor (PgR), controversy has existed about the presence of the estrogen receptor (ER) in these tumours. We have investigated the presence of both ER and PgR in a series of 20 human meningiomas, spanning the main histol